Philip J Mease, MD: Bimekizumab Demonstrates Favorable Efficacy Compared with Other DMARDs for PsA : vimarsana.com

Philip J Mease, MD, highlights recent data comparing the safety and efficacy of bimekizumab with other DMARDs for the treatment of PsA.

Related Keywords

Philipj Mease , Swedish Medical Center , University Of Washington School Medicine , American College Of Rheumatology , Washington School , American College , Preferred Reporting Items , Match Adjusted Indirect Comparison ,